Peter Attia· MD
i've never seen a person yet who couldn't tolerate a PCSK9 inhibitor where you inject an antibbody into them that binds to a protein and shuts it off that's that that's really a good example
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
i've never seen a person yet who couldn't tolerate a PCSK9 inhibitor where you inject an antibbody into them that binds to a protein and shuts it off that's that that's really a good example
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
never seen a person yet who couldn't tolerate a PCSK9 inhibitor where you inject an antibbody into them that binds to a protein and shuts it off.